BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 38823919)

  • 1. β-Glucan-A promising immunocyte-targeting drug delivery vehicle: Superiority, applications and future prospects.
    He L; Zhu Z; Qi C
    Carbohydr Polym; 2024 Sep; 339():122252. PubMed ID: 38823919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioinspired yeast-based β-glucan system for oral drug delivery.
    Wu Y; Li P; Jiang Z; Sun X; He H; Yan P; Xu Y; Liu Y
    Carbohydr Polym; 2023 Nov; 319():121163. PubMed ID: 37567689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta-d-glucan-based drug delivery system and its potential application in targeting tumor associated macrophages.
    Su Y; Chen L; Yang F; Cheung PCK
    Carbohydr Polym; 2021 Feb; 253():117258. PubMed ID: 33278940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Designing an immunocyte-targeting delivery system by use of beta-glucan.
    Miyamoto N; Mochizuki S; Sakurai K
    Vaccine; 2018 Jan; 36(1):186-189. PubMed ID: 29174675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chiral Active β-Glucan Nanoparticles for Synergistic Delivery of Doxorubicin and Immune Potentiation.
    Huang J; Wu C; Tang S; Zhou P; Deng J; Zhang Z; Wang Y; Wang Z
    Int J Nanomedicine; 2020; 15():5083-5095. PubMed ID: 32764938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Yeast glucan particles: An express train for oral targeted drug delivery systems.
    Yang F; Shang S; Qi M; Xiang Y; Wang L; Wang X; Lin T; Hao D; Chen J; Liu J; Wu Q
    Int J Biol Macromol; 2023 Dec; 253(Pt 5):127131. PubMed ID: 37776921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The correlation between adhesion of schizophyllan to yeast glucan and its effect on regeneration of yeast protoplast.
    Hisamatsu M; Mishima T; Teranishi K; Yamada T
    Carbohydr Res; 1997 Feb; 298(1-2):117-21. PubMed ID: 9076934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucans and applications in drug delivery.
    Lin H; Han R; Wu W
    Carbohydr Polym; 2024 May; 332():121904. PubMed ID: 38431411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular dynamics studies of side chain effect on the beta-1,3-D-glucan triple helix in aqueous solution.
    Okobira T; Miyoshi K; Uezu K; Sakurai K; Shinkai S
    Biomacromolecules; 2008 Mar; 9(3):783-8. PubMed ID: 18257529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological, structural, and drug delivery properties and applications of 1,3-β-glucans.
    Lehtovaara BC; Gu FX
    J Agric Food Chem; 2011 Jul; 59(13):6813-28. PubMed ID: 21609131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modular formation of hyaluronic acid/β-glucan hybrid nanogels for topical dermal delivery targeting skin dendritic cells.
    Kim H; Lee S; Ki CS
    Carbohydr Polym; 2021 Jan; 252():117132. PubMed ID: 33183591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inclusion of cut and as-grown single-walled carbon nanotubes in the helical superstructure of schizophyllan and curdlan (beta-1,3-glucans).
    Numata M; Asai M; Kaneko K; Bae AH; Hasegawa T; Sakurai K; Shinkai S
    J Am Chem Soc; 2005 Apr; 127(16):5875-84. PubMed ID: 15839686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. β-glucan as a new tool in vaccine development.
    Vetvicka V; Vannucci L; Sima P
    Scand J Immunol; 2020 Feb; 91(2):e12833. PubMed ID: 31544248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral Gavage Delivery of PR8 Antigen with β-Glucan-Conjugated GRGDS Carrier to Enhance M-Cell Targeting Ability and Induce Immunity.
    Lee DY; Nurunnabi M; Kang SH; Nafiujjaman M; Huh KM; Lee YK; Kim YC
    Biomacromolecules; 2017 Apr; 18(4):1172-1179. PubMed ID: 28278374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of β-glucan particles as dual-function carriers for poorly soluble drugs.
    Šalamúnová P; Saloň I; Ruphuy G; Kroupová J; Balouch M; Hanuš J; Štěpánek F
    Eur J Pharm Biopharm; 2021 Nov; 168():15-25. PubMed ID: 34411641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the potency of a variety of β-glucans to induce cytokine production in human whole blood.
    Noss I; Doekes G; Thorne PS; Heederik DJ; Wouters IM
    Innate Immun; 2013 Feb; 19(1):10-9. PubMed ID: 22653750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding assay of human Dectin-1 variants to DNA/β-glucan complex for active-targeting delivery of antisense DNA.
    Fujiwara N; Izumi H; Kira R; Morimoto Y; Mochizuki S; Sakurai K
    Carbohydr Res; 2021 Feb; 500():108219. PubMed ID: 33339585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring β-glucan as a micro-nano system for oral delivery targeted the colon.
    Dong QQ; Wu Q; Lu Y; Shi Y; Yang KD; Xu XL; Chen W
    Int J Biol Macromol; 2023 Dec; 253(Pt 6):127360. PubMed ID: 37827417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Naphthalene-hydrophobized β-1,3-glucan nanogel for doxorubicin delivery to immunocytes.
    Maeda K; Mochizuki S; Sanada Y; Sakurai K
    Bioorg Med Chem Lett; 2014 Apr; 24(8):1880-3. PubMed ID: 24684841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure, preparation, modification, and bioactivities of β-glucan and mannan from yeast cell wall: A review.
    Liu Y; Wu Q; Wu X; Algharib SA; Gong F; Hu J; Luo W; Zhou M; Pan Y; Yan Y; Wang Y
    Int J Biol Macromol; 2021 Mar; 173():445-456. PubMed ID: 33497691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.